HIVE MENDOCINO COOPERATIVE – Trademark Portfolio
Entity Type: 16
HIVE MENDOCINO COOPERATIVE holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HIVE MENDOCINO. The owner is based in UKIAH, CA.
21401 ORR SPRINGS RD.
UKIAH, CA 95482
Showing of trademarks Trademarks
Trademark Classifications
HIVE MENDOCINO COOPERATIVE's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does HIVE MENDOCINO COOPERATIVE have?
HIVE MENDOCINO COOPERATIVE has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does HIVE MENDOCINO COOPERATIVE file in?
HIVE MENDOCINO COOPERATIVE files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are HIVE MENDOCINO COOPERATIVE's most well-known trademarks?
HIVE MENDOCINO COOPERATIVE's registered trademark portfolio includes well-known marks such as HIVE MENDOCINO. These are among 2 currently registered trademarks in the portfolio.
What is HIVE MENDOCINO COOPERATIVE's trademark registration success rate?
HIVE MENDOCINO COOPERATIVE has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.